North America,

A stake acquisition in US venture Illexcor allows India's Zydus to get in on the ground floor for a potential once-daily sickle cell disease treatment. The candidate showed promising preclinical results in a field that has yielded mixed outcomes for global majors like Novartis, Pfizer and Novo Nordisk

US President Trump’s threat of a “25% or higher” import tariff on pharmaceuticals sends ripples through an already uncertain environment. With about half of generics sourced from India, captains of industry read between the lines

Darrin Schellin leads Pharma Tech; PLT expands leadership with Weiss as brand mmanagement head; Tuttle joins ProPharma as CFO; Burgher leads Arbonne marketing, growth; Evvy appoints first medical chief; Vitaquest appoints David Alcaraz quality assurance head; and Lemon Water leadership in transition from founder.